Point-of-care glucose testing is a process of testing blood glucose levels of the patient at bedside. It does not involve the patient going to the hospital/laboratory for monitoring the diabetes condition. Point-of-care glucose testing is majorly used for the management of diabetes condition in patients. Different strips, lancets, and meters are used to monitor blood glucose levels in the patients. There has been an observed rise in prevalence of both type 1 and type 2 diabetes throughout the world, and in Japan. This makes way for proper monitoring of blood glucose levels in the patients. This increase in maintenance surges the demand for point-of-care glucose testing devices in Japan. This fosters the growth of the Japan point-of-care glucose testing market. Further, the ease of availability of economic POC test strips makes it easy for patients to test the blood glucose levels from the comfort of their home. The government of Japan has initiated the adoption of new technologies and is taking an effort to make these available for patients at an affordable rate, which in turn, increases the growth of the market. There is a need for installing glucose meters in different healthcare sectors in Japan. However, this is expensive for the government of Japan, thus limiting the market growth.
There is an increase in demand for direct-to-consumer wireless powered POC monitoring system, which helps the customer track the blood glucose levels from home, and helps laboratory to maintain a record of the same without visiting the customer. This increase in demand creates lucrative opportunities for the key players operating in the Japan point-of-care glucose monitoring market.
The Japan point-of-care glucose testing market is segmented on the basis of product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips, and blood-glucose meter. The blood-glucose meter segment is further bifurcated into Lifescan one touch ultra & Lifescan one touch verio; Accuchek Aviva Plus & Accuchek; FreeStyle Lite & FreeStyle precision neo; Contour Next; and others. On the basis of application, the market is classified into type-1 diabetes, and type-2 diabetes. As per end user, it is segregated into hospitals & clinics, home care settings, and others.
Key players operating in the Italy point-of-care glucose testing market include Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Siemens Healthcare, Arkray Inc., Otsuka Pharmaceutical Co., FUJIFILM Holdings Corp., ETHICON, Inc., Novo Nordisk A/S and OLYMPUS CORPORATIONAbbott Laboratories launched several products such as FreeStyle Libre diagnostic system and FreeStyle Libre 2 integrated continuous glucose monitoring system to enable accurate glucose monitoring for the patient. Similarly, Roche Diagnostics also launched new products such as the Scanadu Scouter, which is a connected handheld device used for detecting glucose levels. Further, five emerging companies in the market include Bionovate, ARKRAY USA Inc., Diatrics, Ciphergen Biosystems, and LifeScan.
The Japan point-of-care glucose testing market is expected to witness growth during the forecast period. Companies in Japan are focusing on partnerships and collaborations to establish themselves in the competitive market. Many companies are focusing on investing in biosensors, optical imaging, and metabolomics for enhanced glucose testing.
Japan Point-of-Care Glucose Testing Market Report Highlights
| Aspects | Details |
 Forecast period | 2022 - 2032 |
 Report Pages | 86 |
 By Product Type |
|
 By Application |
|
 By End User |
|
 Key Market Players | Sysmex Corporation, ETHICON, Inc., Siemens Healthcare, Abbott Laboratories, FUJIFILM Holdings Corp., Roche Diagnostics, OLYMPUS CORPORATION, Novo Nordisk A/S, Otsuka Pharmaceutical Co., Arkray Inc. |
The Japan Point-of-Care Glucose Testing Market is estimated to reach $216.7 million by 2032
Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Siemens Healthcare, Arkray Inc., Otsuka Pharmaceutical Co., FUJIFILM Holdings Corp., ETHICON, Inc., Novo Nordisk A/S, OLYMPUS CORPORATION are the leading players in Japan Point-of-Care Glucose Testing Market
1. Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
2. Analyze the key strategies adopted by major market players in japan point-of-care glucose testing market.
3. Assess and rank the top factors that are expected to affect the growth of japan point-of-care glucose testing market.
4. Top Player positioning provides a clear understanding of the present position of market players.
5. Detailed analysis of the japan point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
6. Identify key investment pockets for various offerings in the market.
Japan Point-of-Care Glucose Testing Market is classified as by product type, by application, by end user
Loading Table Of Content...
Loading Research Methodology...
